Neuromuscular Diseases: From Cellular Mechanisms, Pathogenesis, and Therapeutics

Dear Colleagues,

Neuromuscular diseases represent a very broad and complicated area of medical and biological sciences. Although significant progress has been made, pathological processes still have to be better characterized in numerous neuromuscular diseases, including in inflammatory myopathies and neurodegenerative disorders such as amyotrophic lateral sclerosis. In clinical settings, insufficient knowledge of etiopathology is, in many cases, reflected by the constant need for the development of better, more efficient diagnostic tools, the identification of reliable prognostic as well as predictive factors, and the introduction of novel therapeutic measures.

In this Special Issue we invite researchers to present original and review articles focused on the most recent evidence in basic research fields, describing the current status of and new perspectives in the areas of the etiopathology and differential diagnostics of neuromuscular diseases (with special emphasis laid on idiopathic inflammatory myopathies and amyotrophic lateral sclerosis), the application of modern solutions in the therapy and monitoring (including clinical, radiological, molecular parameters, digital systems and others) of the clinical courses of diseases and treatment responses, and new insights into the cellular as well as molecular mechanisms responsible for neuromuscular diseases.

Prof. Dr. Mariusz Stasiolek
Dr. Claudia Crosio
Prof. Dr. Joanna Makowska
Dr. Mariola Świderek-Matysiak
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• neuromuscular disorders
• idiopathic inflammatory myopathy
• myositis
• amyotrophic lateral sclerosis
• autoimmune diseases
• neurodegenerative diseases
• biomarkers
• immune therapy
• immunopathology
• environmental and genetic factors
• molecular mechanisms